WOCKPHARMA.BOWOCKPHARMA.BOBSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank43
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Latest
-9.85%
↑ 21% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive declineDecelerating
Average
-12.51%
Historical baseline
PeriodValue
2025-9.85%
2024-6.38%
2023-1.40%
2022-16.86%
2021-17.34%
2020-28.46%
20191.27%
2018-27.68%
2017-20.22%
20161.85%